Follow-The-Filings

Security · featured owners

SUPN Supernus Pharmaceuticals, Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 5.0%
  • $20M
  • 1 exit

SUPN (Supernus Pharmaceuticals, Inc.) is held in 2 featured 13F books as of 2026 Q2. Michael Krensavage - Krensavage Asset Management is the largest tracked holder by portfolio weight (5.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 5.0% (Michael Krensavage - Krensavage Asset Management) · not free-float ownership

  1. Michael Krensavage 5.0%
  2. Third Avenue Management 1.1%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Michael Krensavage - Krensavage Asset Management 2026 Q2 5.0% Hold 280,681 $13M History
Third Avenue Management 2026 Q2 1.1% Hold 152,724 $7M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 4,000 $207K History

2 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,5.02,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02 Filing Doc
8-K 1.01,2.01,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Aug 12, 2026 · 5 forms Filing Doc
4 Period Jul 29, 2026 · 5 forms Filing Doc
4 Period Mar 16, 2026 Filing Doc
4 Period Mar 12, 2026 Filing Doc
4 Period Mar 13, 2026 Filing Doc
4 Period Mar 6, 2026 · 4 forms Filing Doc
4 Period Mar 5, 2026 Filing Doc
4 Period Feb 28, 2026 · 3 forms Filing Doc
4 Period Feb 25, 2026 · 2 forms Filing Doc

Updated 19 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $661.82M $718.95M
Gross profit * $583.91M $644.39M
Gross margin * 88.2% 89.6%
Net income $73.86M -$38.55M
Net margin * 11.2% -5.4%

Balance sheet

Metric FY2024 FY2025
Total current assets $686.07M $644.18M
Total non-current assets * $682M $808.47M
Total assets $1.37B $1.45B
Total current liabilities $292.4M $338.17M
Total non-current liabilities * $39.94M $52.76M
Total equity $1.04B $1.06B

Cash flow

Metric FY2024 FY2025
Cash from operations $171.95M $47.33M
Cash from investing -$189.87M $4.11M
Cash from financing $12.19M $9.13M
Net change in cash -$5.72M $60.57M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders